NCT02135133 A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL Status COMPLETED Phase PHASE2
NCT02130661 Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers Status WITHDRAWN Phase PHASE1
NCT02130635 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE2
NCT02130193 Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations Status COMPLETED Phase PHASE2
NCT02124798 A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector Status COMPLETED Phase PHASE2
NCT02124785 Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix® Status WITHDRAWN Phase PHASE4
NCT02120352 A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects Status COMPLETED Phase PHASE2
NCT02119325 The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population Status COMPLETED Phase NA
NCT02119286 Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2 Status COMPLETED Phase PHASE3
NCT02119260 A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients Status COMPLETED Phase PHASE2
NCT02119156 Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients Status COMPLETED Phase PHASE3
NCT02116504 Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients Status UNKNOWN Phase NA
NCT02114333 Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds Status COMPLETED Phase PHASE1
NCT02113436 Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma Status COMPLETED Phase PHASE4
NCT02112890 Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico Status COMPLETED Phase N/A
NCT02110355 A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT02106403 A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray Status COMPLETED Phase NA
NCT02106390 Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants Status COMPLETED Phase PHASE3